Fisher & Paykel Healthcare Corporation Limited
FPH.AU
| Exchange: | AU |
| Currency | Australian Dollar |
| Open Figi: | BBG000CLWTV6 |
| ISIN: | NZFAPE0001S2 |
| LEI: | 254900ZELZHKNBNS9K28 |
| Primary Ticker: | FPH.NZ |
| Fiscal Year End: | March |
| Sector: | Healthcare |
| Industry: | Medical Instruments & Supplies |
| Gic Sector: | Health Care |
| Gic Group: | Health Care Equipment & Services |
| Gic Industry: | Health Care Equipment & Supplies |
| Gic Sub Industry: | Health Care Supplies |
| Description: | Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand. |
| Address: | 15 Maurice Paykel Place, Auckland, New Zealand, 2013 |
| Website: | https://www.fphcare.com |
| Full Time Employees: | 6391 |
| Updated On: | 2024-04-03 |
Highlights
| Market Capitalization: | 13506343936 |
| Market Capitalization Mln: | 13506.34 |
| EBITDA: | 438400000 |
| PE Ratio: | 56.58 |
| PEG Ratio: | 4.46 |
| Wall Street Target Price: | 22.12 |
| Book Value: | 3.01 |
| Dividend Share: | 0.41 |
| Dividend Yield: | 0.01 |
| Earnings Share: | 0.41 |
| Most Recent Quarter: | 2023-09-30 |
| Profit Margin: | 0.15 |
| Operating Margin TTM: | 0.18 |
| Return On Assets TTM: | 0.09 |
| Return On Equity TTM: | 0.16 |
| Revenue TTM: | 1694200064 |
| Revenue Per Share TTM: | 2.92 |
| Quarterly Revenue Growth YOY: | 0.16 |
| Gross Profit TTM: | 938400000 |
| Diluted Eps TTM: | 0.41 |
| Quarterly Earnings Growth YOY: | 0.11 |
Valuation
| Trailing PE: | 56.58 |
| Forward PE: | 42.91 |
| Price Sales TTM: | 7.97 |
| Price Book MRQ: | 8.40 |
| Enterprise Value: | 13797603163 |
| Enterprise Value Revenue: | 8.06 |
| Enterprise Value Ebitda: | 29.26 |
Shares
| Shares Outstanding: | 582169984 |
| Shares Float: | 579864993 |
| Percent Insiders: | 9.41 |
| Percent Institutions: | 38.45 |
Technicals
| Beta: | 0.40 |
| 52 Week High: | 25.61 |
| 52 Week Low: | 18.42 |
| 50 Day MA: | 22.89 |
| 200 Day MA: | 21.60 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.33 |
| Forward Annual Dividend Yield: | 0.01 |
| Payout Ratio: | 0.01 |
| Ex Dividend Date: | 2023-12-05 |
| Last Split Factor: | 5:1 |
| Last Split Date: | 2004-09-27 |
Holders
| Name: | Vanguard International Share Index-Total Intl Share Indx |
| Date: | 2020-10-31 |
| Total Shares: | 1.52 |
| Current Shares: | 875047 |
| Name: | Price (T.Rowe) International Discovery Fund |
| Date: | 2021-01-31 |
| Total Shares: | 0.92 |
| Current Shares: | 537263 |
| Name: | Smallcap World Fund |
| Date: | 2020-12-31 |
| Total Shares: | 0.82 |
| Current Shares: | 471650 |
| Name: | Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund |
| Date: | 2020-12-31 |
| Total Shares: | 0.63 |
| Current Shares: | 362367 |
| Name: | Invesco Oppenheimer International Small-Mid Company Fund |
| Date: | 2021-01-31 |
| Total Shares: | 0.49 |
| Current Shares: | 284820 |
| Name: | New Perspective Fund Inc |
| Date: | 2020-12-31 |
| Total Shares: | 0.47 |
| Current Shares: | 269900 |
| Name: | i Shares Core MSCI EAFE ETF |
| Date: | 2021-02-28 |
| Total Shares: | 0.44 |
| Current Shares: | 260629 |
| Name: | American Funds Insurance Ser-Global Growth Fund |
| Date: | 2020-12-31 |
| Total Shares: | 0.44 |
| Current Shares: | 255000 |
| Name: | Columbia Acorn International Fund |
| Date: | 2020-12-31 |
| Total Shares: | 0.34 |
| Current Shares: | 201359 |
| Name: | i Shares MSCI Eafe ETF |
| Date: | 2021-02-28 |
| Total Shares: | 0.33 |
| Current Shares: | 190269 |
Earnings
| Report Date: | 2024-05-21 |
| Date: | 2024-03-31 |
| Currency: | NZD |
| Eps Difference: | -0.00 |
| Surprise Percent: | -10 |
| Report Date: | 2024-02-20 |
| Date: | 2023-12-31 |
| Currency: | NZD |
| Report Date: | 2023-11-28 |
| Date: | 2023-09-30 |
| Currency: | NZD |
| Eps Actual: | 0.18 |
| Eps Difference: | 0.17 |
| Surprise Percent: | 9988.88 |
| Report Date: | 2023-08-30 |
| Date: | 2023-06-30 |
| Currency: | NZD |
| Report Date: | 2023-05-25 |
| Date: | 2023-03-31 |
| Currency: | NZD |
| Report Date: | 2023-02-16 |
| Date: | 2022-12-31 |
| Currency: | NZD |
| Report Date: | 2022-11-28 |
| Date: | 2022-09-30 |
| Currency: | NZD |
| Report Date: | 2022-08-31 |
| Date: | 2022-06-30 |
| Currency: | NZD |
| Report Date: | 2022-05-24 |
| Date: | 2022-03-31 |
| Currency: | NZD |
| Report Date: | 2022-02-10 |
| Date: | 2021-12-31 |
| Currency: | NZD |
| Report Date: | 2021-11-24 |
| Date: | 2021-09-30 |
| Currency: | NZD |
| Report Date: | 2021-08-17 |
| Date: | 2021-06-30 |
| Currency: | NZD |
| Report Date: | 2018-05-20 |
| Date: | 2018-03-31 |
| Currency: | NZD |
| Report Date: | 2017-11-20 |
| Date: | 2017-09-30 |
| Currency: | NZD |
| Report Date: | 2017-05-21 |
| Date: | 2017-03-31 |
| Currency: | NZD |
| Report Date: | 2016-11-21 |
| Date: | 2016-09-30 |
| Currency: | NZD |
| Report Date: | 2003-03-31 |
| Date: | 2003-03-31 |
| Currency: | NZD |
| Eps Actual: | 0.02 |
| Report Date: | 2002-12-31 |
| Date: | 2002-12-31 |
| Currency: | NZD |
| Eps Actual: | 0.04 |
| Date: | 2020-03-31 |
| Period: | +1y |
| Revenue Estimate Avg: | 1213790000.00 |
| Revenue Estimate Low: | 1179780000.00 |
| Revenue Estimate High: | 1250000000.00 |
| Revenue Estimate Number Of Analysts: | 8.00 |
| Revenue Estimate Growth: | 0.12 |
| Eps Trend7days Ago: | 0.42 |
| Eps Trend30days Ago: | 0.42 |
| Eps Trend60days Ago: | 0.42 |
| Eps Trend90days Ago: | 0.42 |
| Date: | 2019-09-30 |
| Period: | +1q |
| Revenue Estimate Avg: | 1082280000.00 |
| Revenue Estimate Low: | 1069770000.00 |
| Revenue Estimate High: | 1105000000.00 |
| Revenue Estimate Number Of Analysts: | 8.00 |
| Revenue Estimate Growth: | 0.10 |
| Date: | 2019-06-30 |
| Revenue Estimate Avg: | 1082280000.00 |
| Revenue Estimate Low: | 1069770000.00 |
| Revenue Estimate High: | 1105000000.00 |
| Revenue Estimate Number Of Analysts: | 8.00 |
| Revenue Estimate Growth: | 0.10 |
| Date: | 2019-03-31 |
| Revenue Estimate Avg: | 1082280000.00 |
| Revenue Estimate Low: | 1069770000.00 |
| Revenue Estimate High: | 1105000000.00 |
| Revenue Estimate Number Of Analysts: | 8.00 |
| Revenue Estimate Growth: | 0.10 |
| Eps Trend7days Ago: | 0.37 |
| Eps Trend30days Ago: | 0.37 |
| Eps Trend60days Ago: | 0.37 |
| Eps Trend90days Ago: | 0.37 |
| Date: | 2024-03-31 |
| Eps Actual: | 0.18 |
| Date: | 2023-03-31 |
| Date: | 2022-03-31 |
| Date: | 2018-03-31 |
| Date: | 2017-03-31 |
| Date: | 2003-03-31 |
| Eps Actual: | 0.06 |